Electronic Investigator Site File (eISF)

Version Control

STRATA-Local-Site-File-Version-Control-V3.0

 

General Correspondence

There are currently no documents in this section.

 

Screening and Recruitment Records

Screening and Recruitment Log

2021.12.01 STRATA [SITE] Individual Screening & Group Activity Log V2.0

Superseded

2021.06.28 STRATA Screening and Recording Log V1.0

 

Site Information and Research Personnel

Delegation Log

Template

2021.08.12 Site Delegation Log v3.0

Superseded

2021.08.03 Site Delegation Log v2.0

2021.02.12 Site Delegation Log v1.0

 

UoB Associate Status

Please contact central study team: strata-rct@bristol.ac.uk

Superseded

Associate-request-form

 

Site Set Up

Site Set Up

 

Study Specific Documents

Study Specific Documents

 

Health Research Authority and Local R&D

Initial Approval letter

270727 HRA and HCRW approval 02.02.2021

270727 initial assessment letter 13.01.2021

Organisation Information Document

Outline Organisation Information Document

2020.11.25 STRATA Organisation_Information_Document_Non-Commercial_V1.0

SoECAT

2020.10.15 STRATA SoECAT_NIHRHTA_ALL_Rai_FinalV1.0

 

Research Ethics Committee

Initial Application

2021.01.11 STRATA Initial REC HRA Application

V1.0 270727 conditions met 02.02.2021

270727 favourable opinion with conditions 01.02.2021

Amendments

Amendment 01

270727 2019-4556 SubAm1 080721

21FT0008AM01_Favourable_opinion_of_a_substantial_amendment

IRAS PROJECT ID 270727 REC Reference 21FT0008 Confirmation of favourable opinion for substantial amendment

Amendment 02

2019-4556 NSA02 Approval

270727 2019-4556 NSA2 060821

Amendment 03

270727 2019-4556 SubAm3 031121

270727 HRA Approval SubAm03

Favourable_opinion_of_a_substantial_amendment

Amendment 04

270727 2019-4556 NSA4 161221

270727 NSA4 Amendment confirmation

Amendment 05

270727 2019-4556 SubAm5 221221 Amendment 05

HRA Approval IRAS_270727

Favourable_opinion_of_a_substantial_amendment (17)

Amendment 06

270727 2019-4556 NSA6 200122

IRAS270727. Amendment

Amendment 07

270727 2019-4556 NSA7 010222

270727 NSA7 Amendment confirmation

Amendment 08

IRAS_270727_Favourable_opinion_of_a_substantial_amendment

IRAS Project ID 270727. HRA and HCRW Approval for the Amendment

270727 2019-4556 SubAm8 040322

Amendment 09

270727 2019-4556 NSA9 311022

RE STRATA Ethics amendment Id nr 1868471

Amendment 10

270727 2019-4556 NSA10 061222

IRAS 270727. Amendment

Amendment 11

Re-issued14April202322SC0296AM11Favourable_opinion_of_a_substantial_amendment – 2022-12-28T094507.642 (1)

2019 004312 66 270727 2019-4556 SubAm11 151222

IRAS Project ID 270727. HRA and HCRW Approval for the Amendment

Superseded

22SC0296AM11Favourable_opinion_of_a_substantial_amendment – 2022-12-28T094507.642

Amendment 12

270727 2019-4556 SubAm12 080223

22SC0296AM12Favourable_opinion_of_a_substantial_amendment7March2023

IRAS 270727 HRA Approval 22SC0296 SubAm12

Amendment 13

270727 2019-4556 NSA13 130923

NSA13 270727 Amendment Confirmation

 

MHRA IMP Information

IMP Pharmacy Related Documents

IMP Label

2020.12.11 STRATA UK IMP Bottle Label 25mg Sertraline_Placebo V1.0

2020.12.11 STRATA UK IMP Bottle Label 50mg Sertraline_Placebo V1.0

IMPD

07-Oct-2022_STRATA_IMPD_V2.0_clean[1]

Attachment 1 – FDA – Aurobino Sertraline Monograph

Attachment 1 – SmPC – Crescent 50mg tablets

Attachment 2 – QG TSE-BSE 2019

Attachment 3 – Qualicaps Example – CoA

Attachment 4 – BSE TSE Vivapur

Attachment 5 – Vivapur CoA

Superseded

2020.07.16 STRATA IMPD V1.0

MIA

Renaclinical GMP Certificate MIA (IMP) 49160

Renaclinical MIA(IMP) 49160 v7

MIA(IMP) LICENCE

Pharmacy Manual

10-Nov-2022_STRATA_Pharmacy_Manual_V3.0_clean[1]

Superseded

2021.05.26 STRATA Pharmacy Manual V2.0

Prescription Form

2021.03.31 STRATA Prescription Form – Starter Pack Week 0 V2.0

2021.03.31 STRATA Prescription Form – Unscheduled Appointment V2.0

2021.03.31 STRATA Prescription Form – Week 4 V2.0

2021.03.31 STRATA Prescription Form – Week 8 V2.0

2021.03.31 STRATA Prescription Form – Week 12 V2.0

2021.03.31 STRATA Prescription Form – Week 36 V2.0

SmPC

FDA – Aurubindo Sertraline Monograph

SmPC – Crescent 50mg tablets

Initial Application

2020.12.11 STRATA CTA Form V1.0 Signed

2020.12.24 CTA Notice of Acceptance (MHRA Approval)

Amendment 03

Notice of acceptance of Amendment

Amendment 05

2019-4556 SubAm5 Notice of acceptance of Amendment (MHRA Approval)

Amendment 11

Notice of acceptance of Amendment

 

Funding and Sponsorship Arrangements

Sponsor Insurance Documentation

Uni of Bristol – CT VOI 2021-1

Superseded

CT2407 insureconfirm 2020-21

CTR Policy Schedule

Sponsorship Letter

STRATA full sponsor letter 110522 FINAL

Superseded

STRATA full sponsor letter 110122 FINAL

STRATA full sponsor letter 211221 FINAL

STRATA full sponsor letter 071221 FINAL

STRATA full sponsor letter 121121 FINAL

STRATA full sponsor letter 051021 FINAL

STRATA full sponsor letter 120821 FINAL

STRATA full sponsor letter 210721 FINAL with Annex3

 

Contracts

Templates

STRATA mNCA – updated 2021 (FINAL CLEAN)

Model_NC_PIC_Agreement_v1-0_June2019

Superseded

STRATA mNCA

 

CRF Data Collection Form

CRFs are completed on the study database. However, paper alternatives are available upon request.

Baseline

Revised Clinical Interview Schedule (CIS-R)

Not available on website. Please contact the STRATA Central Study Team.

 

Site Training Documents

Site Training Documents

 

Protocol Breaches & Violations

Template

CAPA form Sept23 FINAL to be used for all

Superseded

2021.03.31 STRATA Protocol Deviation Report Form v1.0

 

Monitoring

STRATA _Monitoring Plan_Final V1.0 30.04.21